Here's Why KeyBanc Sees 39% Upside In Nutanix
KeyBanc analyst Thomas Blakey initiated coverage of Nutanix Inc (NASDAQ:NTNX) with an Overweight rating and a $39 price target, suggesting an upside of 38.74%. The recent acceleration, new product cross-sell, and go-to-market partnerships have influenced his above-Street revenue and ACV billings outlook. Blakey further notes that he sees potential rerating with about 50% of…
Benzinga ·